Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

José Alcamí

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|January 10, 2009
[Introduction. A brief history of AIDS]José Alcamí
Enfermedades Infecciosas Y Microbiologia Clinica|January 10, 2009
[Conclusions and perspectives. Maraviroc]José Alcamí
Enfermedades Infecciosas Y Microbiologia Clinica|July 3, 2009
[The HIV replication cycle. Established therapeutic targets and potential targets]José Alcamí
Enfermedades Infecciosas Y Microbiologia Clinica|October 16, 2004
[Advances in the immunopathology of HIV infection]José Alcamí
Enfermedades Infecciosas Y Microbiologia Clinica|March 11, 2011
[Immunopathogenesis of HIV infection]José Alcamí, Mayte Coiras
Current HIV Research|November 9, 2010
Broadly neutralizing antibodies and their significance for HIV-1 vaccinesNuria González, Amparo Alvarez, José Alcamí
The Journal of General Virology|November 21, 2001
MC159L protein from the poxvirus molluscum contagiosum virus inhibits NF-kappaB activation and apoptosis induced by PKRJesús Gil, Joaquín Rullas, José Alcamí, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|August 18, 2018
Current situation of HIV research in SpainJosé Alcamí, Antonio Alemany, Javier Dodero, et al.
Journal of Medical Virology|June 29, 2004
Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitorsMercedes Bermejo, Sonsoles Sánchez-Palomino, Luis Usán, et al.
Retrovirology|December 3, 2008
Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IkappaBalpha and enhances HIV-1 replication in human T lymphocytesMayte Coiras, María Rosa López-Huertas, Elena Mateos, et al.
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Enfermedades Infecciosas Y Microbiologia Clinica|January 10, 2009
[Introduction. A brief history of AIDS]José Alcamí
Enfermedades Infecciosas Y Microbiologia Clinica|January 10, 2009
[Conclusions and perspectives. Maraviroc]José Alcamí
Enfermedades Infecciosas Y Microbiologia Clinica|July 3, 2009
[The HIV replication cycle. Established therapeutic targets and potential targets]José Alcamí
Enfermedades Infecciosas Y Microbiologia Clinica|October 16, 2004
[Advances in the immunopathology of HIV infection]José Alcamí
Enfermedades Infecciosas Y Microbiologia Clinica|March 11, 2011
[Immunopathogenesis of HIV infection]José Alcamí, Mayte Coiras
Current HIV Research|November 9, 2010
Broadly neutralizing antibodies and their significance for HIV-1 vaccinesNuria González, Amparo Alvarez, José Alcamí
The Journal of General Virology|November 21, 2001
MC159L protein from the poxvirus molluscum contagiosum virus inhibits NF-kappaB activation and apoptosis induced by PKRJesús Gil, Joaquín Rullas, José Alcamí, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|August 18, 2018
Current situation of HIV research in SpainJosé Alcamí, Antonio Alemany, Javier Dodero, et al.
Journal of Medical Virology|June 29, 2004
Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitorsMercedes Bermejo, Sonsoles Sánchez-Palomino, Luis Usán, et al.
Retrovirology|December 3, 2008
Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IkappaBalpha and enhances HIV-1 replication in human T lymphocytesMayte Coiras, María Rosa López-Huertas, Elena Mateos, et al.
Pageof 14